{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T12:28:48Z","timestamp":1785932928483,"version":"3.56.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["EDDPMA-May23\/100016"],"award-info":[{"award-number":["EDDPMA-May23\/100016"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The tumour-suppressor protein p53 can form amyloid aggregates resulting in loss of tumour-suppressing functions and leading to tumour formation. The detection of p53 aggregates in cancer cells has been demonstrated but these aggregates have not been detected in liquid biopsies to date, due to the lack of sufficiently sensitive methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We developed an ultrasensitive immunoassay based on the single-molecule array (SiMoA) technology to detect p53 aggregates in plasma, based on antibody capture of the aggregates. We confirmed that the assay detects p53 aggregates using super-resolution imaging. We then investigated the p53 aggregate concentrations in the plasma of 190 pre-surgery glioblastoma (GB) patients and 22 controls using this assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We found that the plasma p53 aggregate levels are significantly elevated in pre-surgery GB patients\u2019 plasma compared to controls. Longitudinal study further reveals that p53 aggregate levels may increase before GB recurrence and decrease following treatment. We also observed raised p53 aggregate concentrations in the plasma of cancer patients with brain metastases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study demonstrates the detection of p53 aggregates in liquid biopsies. Our findings highlight the potential of p53 aggregates as a novel biomarker for glioblastoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-00918-3","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:04:53Z","timestamp":1748005493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Detection of p53 aggregates in plasma of glioma patients"],"prefix":"10.1038","volume":"5","author":[{"given":"Yunzhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-2342","authenticated-orcid":false,"given":"Jeff Y. L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-0604","authenticated-orcid":false,"given":"Matthaios","family":"Pitoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8443-4469","authenticated-orcid":false,"given":"Dorothea","family":"B\u00f6ken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Chintapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-5806","authenticated-orcid":false,"given":"Emre","family":"Fertan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. H.","family":"Danial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Tsang-Pells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fysh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-5689","authenticated-orcid":false,"given":"Richard","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7116-6954","authenticated-orcid":false,"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41591-018-0043-5","volume":"24","author":"A Janic","year":"2018","unstructured":"Janic, A. et al. DNA repair processes are critical mediators of p53-dependent tumor suppression. Nat. Med. 24, 947\u2013953 (2018).","journal-title":"Nat. Med."},{"key":"918_CR2","doi-asserted-by":"crossref","unstructured":"Chen, J. The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression. Cold Spring Harb. Perspect. Med. 6, a026104 (2016).","DOI":"10.1101\/cshperspect.a026104"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman, J. S. & Lowe, S. W. Control of apoptosis by p53. Oncogene 22, 9030\u20139040 (2003).","journal-title":"Oncogene"},{"key":"918_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001008","volume":"2","author":"M Olivier","year":"2010","unstructured":"Olivier, M., Hollstein, M. & Hainaut, P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008 (2010).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"102230","DOI":"10.1016\/j.cbpa.2022.102230","volume":"72","author":"K Kwan","year":"2023","unstructured":"Kwan, K., Castro-Sandoval, O., Gaiddon, C. & Storr, T. Inhibition of p53 protein aggregation as a cancer treatment strategy. Curr. Opin. Chem. Biol. 72, 102230 (2023).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"15190","DOI":"10.1073\/pnas.93.26.15190","volume":"93","author":"AG Ostermeyer","year":"1996","unstructured":"Ostermeyer, A. G., Runko, E., Winkfield, B., Ahn, B. & Moll, U. M. Cytoplasmically sequestered wild-type p53 protein in neuroblastoma is relocated to the nucleus by a C-terminal peptide. Proc. Natl Acad. Sci. USA 93, 15190\u201315194 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"29112","DOI":"10.18632\/oncotarget.25631","volume":"9","author":"DC Ferraz da Costa","year":"2018","unstructured":"Ferraz da Costa, D. C. et al. Resveratrol prevents p53 aggregation in vitro and in breast cancer cells. Oncotarget 9, 29112\u201329122 (2018).","journal-title":"Oncotarget"},{"key":"918_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac128","volume":"1","author":"N Iwahashi","year":"2022","unstructured":"Iwahashi, N. et al. Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis. PNAS Nexus 1, pgac128 (2022).","journal-title":"PNAS Nexus"},{"key":"918_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu, W. et al. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol. Res. 171, 105780 (2021).","journal-title":"Pharmacol. Res."},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow, J. E. et al. Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N. Engl. J. Med. 372, 2499\u20132508 (2015).","journal-title":"N. Engl. J. Med."},{"key":"918_CR11","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. The p53 pathway in glioblastoma. Cancers 10, 297 (2018).","DOI":"10.3390\/cancers10090297"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11060-019-03318-5","volume":"147","author":"LR Olafson","year":"2020","unstructured":"Olafson, L. R., Gunawardena, M., Nixdorf, S., McDonald, K. L. & Rapkins, R. W. The role of TP53 gain-of-function mutation in multifocal glioblastoma. J. Neurooncol. 147, 37\u201347 (2020).","journal-title":"J. Neurooncol."},{"key":"918_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100820","volume":"23","author":"MM Pedrote","year":"2020","unstructured":"Pedrote, M. M. et al. Oncogenic gain of function in glioblastoma is linked to mutant p53 amyloid oligomers. iScience 23, 100820 (2020).","journal-title":"iScience"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ccell.2015.12.002","volume":"29","author":"A Soragni","year":"2016","unstructured":"Soragni, A. et al. A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas. Cancer Cell 29, 90\u2013103 (2016).","journal-title":"Cancer Cell"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tibs.2014.04.001","volume":"39","author":"JL Silva","year":"2014","unstructured":"Silva, J. L., Gallo, C. V. D. M., Costa, D. C. F. & Rangel, L. P. Prion-like aggregation of mutant p53 in cancer. Trends Biochem. Sci. 39, 260\u2013267 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"918_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595\u2013599 (2010).","journal-title":"Nat. Biotechnol."},{"key":"918_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","volume":"8","author":"D Li","year":"2019","unstructured":"Li, D. & Mielke, M. M. An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform. Neurol. Ther. 8, 73\u201382 (2019).","journal-title":"Neurol. Ther."},{"key":"918_CR19","doi-asserted-by":"crossref","unstructured":"Wilson, D. H. et al. The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J. Lab. Autom. 21, 533\u2013547 (2016).","DOI":"10.1177\/2211068215589580"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10549-021-06474-3","volume":"192","author":"C Morasso","year":"2022","unstructured":"Morasso, C. et al. Fast quantification of extracellular vesicles levels in early breast cancer patients by single molecule detection array (SiMoA). Breast Cancer Res. Treat. 192, 65\u201374 (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"918_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep11034","volume":"5","author":"SM Schubert","year":"2015","unstructured":"Schubert, S. M. et al. Ultra-sensitive protein detection via single molecule arrays towards early stage cancer monitoring. Sci. Rep. 5, 11034 (2015).","journal-title":"Sci. Rep."},{"key":"918_CR22","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen, P. Y. et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J. Clin. Oncol. 28, 1963\u20131972 (2010).","journal-title":"J. Clin. Oncol."},{"key":"918_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100499","volume":"3","author":"Z Xia","year":"2023","unstructured":"Xia, Z. et al. A computational suite for the structural and functional characterization of amyloid aggregates. Cell Rep. Methods 3, 100499 (2023).","journal-title":"Cell Rep. Methods"},{"key":"918_CR24","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41557-020-0506-4","volume":"12","author":"M Di Antonio","year":"2020","unstructured":"Di Antonio, M. et al. Single-molecule visualization of DNA G-quadruplex formation in live cells. Nat. Chem. 12, 832\u2013837 (2020).","journal-title":"Nat. Chem."},{"key":"918_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ymeth.2019.05.008","volume":"174","author":"A Jimenez","year":"2020","unstructured":"Jimenez, A., Friedl, K. & Leterrier, C. About samples, giving examples: optimized single molecule localization microscopy. Methods 174, 100\u2013114 (2020).","journal-title":"Methods"},{"key":"918_CR26","volume":"2","author":"JYL Lam","year":"2022","unstructured":"Lam, J. Y. L. et al. An economic, square-shaped flat-field illumination module for TIRF-based super-resolution microscopy. Biophys. Rep. 2, 100044 (2022).","journal-title":"Biophys. Rep."},{"key":"918_CR27","doi-asserted-by":"crossref","unstructured":"Edelstein, A. D. et al. Advanced methods of microscope control using \u03bcManager software. J. Biol. Methods 1, e10 (2014).","DOI":"10.14440\/jbm.2014.36"},{"key":"918_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1093\/bioinformatics\/btu202","volume":"30","author":"M Ovesn\u00fd","year":"2014","unstructured":"Ovesn\u00fd, M., K\u0159\u00ed\u017eek, P., Borkovec, J., \u0160vindrych, Z. & Hagen, G. M. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30, 2389\u20132390 (2014).","journal-title":"Bioinformatics"},{"key":"918_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"918_CR30","unstructured":"Ester, M., Kriegel, H.-P., Sander, J. & Xu, X. A density-based algorithm for discovering clusters in large spatial databases with noise. In KDD\u201996 226\u2013231 (ACM, 1996)."},{"key":"918_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jmcb\/mjz010","volume":"11","author":"K Sabapathy","year":"2019","unstructured":"Sabapathy, K. & Lane, D. P. Understanding p53 functions through p53 antibodies. J. Mol. Cell Biol. 11, 317\u2013329 (2019).","journal-title":"J. Mol. Cell Biol."},{"key":"918_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23985-1","volume":"12","author":"L Palanikumar","year":"2021","unstructured":"Palanikumar, L. et al. Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function. Nat. Commun. 12, 3962 (2021).","journal-title":"Nat. Commun."},{"key":"918_CR33","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1021\/ac103161b","volume":"83","author":"DM Rissin","year":"2011","unstructured":"Rissin, D. M. et al. Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range. Anal. Chem. 83, 2279\u20132285 (2011).","journal-title":"Anal. Chem."},{"key":"918_CR34","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1016\/j.bpj.2022.10.013","volume":"121","author":"L Julian","year":"2022","unstructured":"Julian, L. et al. Characterization of full-length p53 aggregates and their kinetics of formation. Biophys. J. 121, 4280\u20134298 (2022).","journal-title":"Biophys. J."},{"key":"918_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature10016","volume":"473","author":"A Jain","year":"2011","unstructured":"Jain, A. et al. Probing cellular protein complexes using single-molecule pull-down. Nature 473, 484\u2013488 (2011).","journal-title":"Nature"},{"key":"918_CR36","doi-asserted-by":"publisher","first-page":"105327","DOI":"10.1016\/j.nbd.2021.105327","volume":"153","author":"JSH Danial","year":"2021","unstructured":"Danial, J. S. H. & Klenerman, D. Single molecule imaging of protein aggregation in dementia: methods, insights and prospects. Neurobiol. Dis. 153, 105327 (2021).","journal-title":"Neurobiol. Dis."},{"key":"918_CR37","doi-asserted-by":"publisher","first-page":"W301","DOI":"10.1093\/nar\/gku399","volume":"42","author":"I Walsh","year":"2014","unstructured":"Walsh, I., Seno, F., Tosatto, S. C. E. & Trovato, A. P. A. S. T. A. 2.0: an improved server for protein aggregation prediction. Nucleic Acids Res. 42, W301\u2013W307 (2014).","journal-title":"Nucleic Acids Res."},{"key":"918_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/bimj.200410135","volume":"47","author":"R Fluss","year":"2005","unstructured":"Fluss, R., Faraggi, D. & Reiser, B. Estimation of the Youden Index and its associated cutoff point. Biom. J. 47, 458\u2013472 (2005).","journal-title":"Biom. J."},{"key":"918_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40164-022-00317-7","volume":"11","author":"J Li","year":"2022","unstructured":"Li, J. et al. p53 amyloid aggregation in cancer: function, mechanism, and therapy. Exp. Hematol. Oncol. 11, 66 (2022).","journal-title":"Exp. Hematol. Oncol."},{"key":"918_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.648808","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. The interplay between tumor suppressor p53 and hypoxia signaling pathways in cancer. Front. Cell Dev. Biol. 9, 648808 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"918_CR41","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603\u20131616 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"918_CR42","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756\u2013760 (2006).","journal-title":"Nature"},{"key":"918_CR43","doi-asserted-by":"crossref","unstructured":"Erices, J. I. et al. Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets. Int. J. Mol. Sci. 24, 7047 (2023).","DOI":"10.3390\/ijms24087047"},{"key":"918_CR44","doi-asserted-by":"publisher","first-page":"620677","DOI":"10.3389\/fmolb.2020.620677","volume":"7","author":"C Olivier","year":"2020","unstructured":"Olivier, C., Oliver, L., Lalier, L. & Vallette, F. M. Drug resistance in glioblastoma: the two faces of oxidative stress. Front. Mol. Biosci. 7, 620677 (2020).","journal-title":"Front. Mol. Biosci."},{"key":"918_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden, K. H. & Prives, C. Blinded by the light: the growing complexity of p53. Cell 137, 413\u2013431 (2009).","journal-title":"Cell"},{"key":"918_CR46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10014-023-00463-8","volume":"40","author":"S Nakasu","year":"2023","unstructured":"Nakasu, S., Deguchi, S. & Nakasu, Y. IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis. Brain Tumor Pathol. 40, 143\u2013157 (2023).","journal-title":"Brain Tumor Pathol."},{"key":"918_CR47","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1007\/s00520-021-06319-1","volume":"29","author":"KT Bui","year":"2021","unstructured":"Bui, K. T., Blinman, P., Kiely, B. E., Brown, C. & Dhillon, H. M. Experiences with scans and scanxiety in people with advanced cancer: a qualitative study. Support. Care Cancer 29, 7441\u20137449 (2021).","journal-title":"Support. Care Cancer"},{"key":"918_CR48","doi-asserted-by":"crossref","unstructured":"Derry-Vick, H. M. et al. Scanxiety among adults with cancer: a scoping review to guide research and interventions. Cancers 15, 1381 (2023).","DOI":"10.3390\/cancers15051381"},{"key":"918_CR49","doi-asserted-by":"publisher","first-page":"921","DOI":"10.5858\/2000-124-0921-HAMA","volume":"124","author":"GG Klee","year":"2000","unstructured":"Klee, G. G. Human anti-mouse antibodies. Arch. Pathol. Lab. Med. 124, 921\u2013923 (2000).","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00918-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00918-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00918-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:04:18Z","timestamp":1748009058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00918-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00918-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K., R.M., K.M.B., J.Y.L.L., D.B., and Y.W. are all inventors on a patent using the detection of p53 aggregates for cancer diagnostics filed by Cambridge Enterprise. The other authors (M.P., Z.Z., R.C., E.F., Z.X., J.S.H.D., G.T., E.F., and L.J.) declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}